Title of the panel discussion:
From Data to Discovery: Shaping the Future of Microbiome Therapeutics
Panel discussion summary
Join us for a dynamic session featuring a panel discussion on the recent developments in the microbiome field. Experts, investors, and biotech leaders will explore key achievements, challenges, and success factors in microbiome-based therapies and especially how data are shaping the future of the field.
Date, time and room information
Monday, May 4, 16:30 - 17:15, room Shanghai 1+2
PharmaBiome AG
PharmaBiome has developed the world’s first true drug-development platform for targeted microbiome therapeutics.
IQVIA AG
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry.
